API
< Back to situations

[PERSON]

rituximab

Featured in 1 tracked story · first seen

Situations

[ACTIVE] [HEALTH] [CN] [US]

Advancements in BTK inhibitor lymphoma treatments

2 clusters · 7 sources · last updated

Latest: FDA grants priority review to BeOne Medicines’ BRUKINSA combination

Recent clinical developments have highlighted the efficacy of Bruton tyrosine kinase (BTK) inhibitor combinations in treating various forms of lymphoma. A phase 2 study conducted at four Chinese centers reported that co